Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies

Annual Review of Physiology

Volumn 71, Issue , 2009, Pages 37-57

  Wallace, Gregory Q ^a   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Dysferlin; Dystrophin; Lamin A C; Nitric oxide synthase; Sarcoglycan

Indexed keywords

BIGLYCAN; CALCIUM ION; CALPAIN; CAVEOLIN 3; DYSFERLIN; DYSTROPHIN; EMERIN; FREE RADICAL; LAMIN A; LAMIN C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SARCOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1;

BECKER MUSCULAR DYSTROPHY; CALCIUM HOMEOSTASIS; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; EXTRACELLULAR MATRIX; GENE MAPPING; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE; MUSCLE REGENERATION; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; X CHROMOSOME; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DYSTROPHIN; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION;

EID: 67149122523     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.010908.163216     Document Type: Review

References (152)

1. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315-319 (Pubitemid 20159538)
2. Yoshida M, Ozawa E. 1990. Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 108:748-752
3. Rybakova IN, Patel JR, Ervasti JM. 2000. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J. Cell Biol. 150:1209-1214
4. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702
5. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, et al. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 84:757-767
6. Heydemann A, Doherty KR, McNally EM. 2007. Genetic modifiers of muscular dystrophy: implications for therapy. Biochim. Biophys. Acta 1772:216-228 (Pubitemid 46127823)
7. Wagner KR. 2002. Genetic diseases of muscle. Neurol. Clin. 20:645-678
8. Rafii MS, Hagiwara H, Mercado ML, Seo NS, Xu T, et al. 2006. Biglycan binds to α- and γ-sarcoglycan and regulates their expression during development. J. Cell Physiol. 209:439-447 (Pubitemid 44484635)
9. Mercado ML, Amenta AR, Hagiwara H, Rafii MS, Lechner BE, et al. 2006. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J. 20:1724-1726 (Pubitemid 44943785)
10. Barton ER. 2006. Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am. J. Physiol. Cell Physiol. 290:C411-19
11. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, et al. 1995. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11:216-218
12. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. 2002. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422 (Pubitemid 34826841)
13. Martin PT. 2007. Congenital muscular dystrophies involving the O-mannose pathway. Curr. Mol. Med. 7:417-425 (Pubitemid 46979705)
14. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, et al. 2001. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10:2851-2859 (Pubitemid 34030916)
15. Hayashi YK, Chou FL, Engvall E, Ogawa M, Matsuda C, et al. 1998. Mutations in the integrin α7 gene cause congenital myopathy. Nat. Genet. 19:94-97 (Pubitemid 28242033)
16. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. 1997. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J. Cell Sci. 110(Pt. 22):2873-2881 (Pubitemid 27514116)
17. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. 2004. Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle. J. Cell Sci. 117:3821-3830 (Pubitemid 39207320)
18. Thompson TG, Chan YM, Hack AA, Brosius M, Rajala M, et al. 2000. Filamin 2 (FLN2): a musclespecific sarcoglycan interacting protein. J. Cell Biol. 148:115-126 (Pubitemid 30046786)
19. Guo C, Willem M, Werner A, Raivich G, Emerson M, et al. 2006. Absence of α7 integrin in dystrophindeficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum. Mol. Genet. 15:989-998 (Pubitemid 43338239)
20. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ. 2006. Severe muscular dystrophy in mice that lack dystrophin and α7 integrin. J. Cell Sci. 119:2185-2195
21. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ. 2001. Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol. 152:1207-1218
22. Mokri B, Engel AG. 1975. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25:1111-1120
23. Straub V, Donahue KM, Allamand V, Davisson RL, Kim YR, Campbell KP. 2000. Contrast agentenhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn. Reson. Med. 44:655-659 (Pubitemid 30769669)
24. Pestronk A, Parhad IM, Drachman DB, Price DL. 1982. Membrane myopathy: morphological similarities to Duchenne muscular dystrophy. Muscle Nerve 5:209-214
25. Menke A, Jockusch H. 1991. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349:69-71 (Pubitemid 21912016)
26. Pasternak C, Wong S, Elson EL. 1995. Mechanical function of dystrophin in muscle cells. J. Cell Biol. 128:355-361
27. Williams MW, Bloch RJ. 1999. Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice. J. Cell Biol. 144:1259-1270
28. Minetti C, Tanji K, Bonilla E. 1992. Immunologic study of vinculin in Duchenne muscular dystrophy. Neurology 42:1751-1754
29. Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, et al. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725-729 (Pubitemid 23273127)
30. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90:3710-3714 (Pubitemid 23111437)
31. Danialou G, Comtois AS, Dudley R, Karpati G, Vincent G, et al. 2001. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 15:1655-1657
32. 2+ homeostasis and of survival in collagenase-isolated muscle fibres from normal and mdx mice. J. Physiol. 542:855-865
33. Robert V, Massimino ML, Tosello V, Marsault R, Cantini M, et al. 2001. Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 276:4647-4651 (Pubitemid 37371345)
34. Turner PR, Fong PY, Denetclaw WF, Steinhardt RA. 1991. Increased calcium influx in dystrophic muscle. J. Cell Biol. 115:1701-1712
35. Bodensteiner JB, Engel AG. 1978. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28:439-446
36. Franco A Jr, Lansman JB. 1990. Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344:670-673 (Pubitemid 20108369)
37. Vandebrouck C, Martin D, Colson-Van Schoor M, Debaix H, Gailly P. 2002. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J. Cell Biol. 158:1089-1096 (Pubitemid 35052691)
38. i and muscle damage in the mdx mouse. J. Physiol. 562:367-380
39. Alderton JM, Steinhardt RA. 2000. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc. Med. 10:268-272 (Pubitemid 32229884)
40. 2+- permeable growth factor-regulated channel. J. Cell Biol. 161:957-967
41. Goll DE, Thompson VF, Li H, Wei W, Cong J. 2003. The calpain system. Physiol. Rev. 83:731-801
42. Vandebrouck A, Ducret T, Basset O, Sebille S, Raymond G, et al. 2006. Regulation of storeoperated calcium entries and mitochondrial uptake by minidystrophin expression in cultured myotubes. FASEB J. 20:136-138 (Pubitemid 43100492)
43. Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, et al. 2008. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat. Med. 14:442-447
44. Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, et al. 2003. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophinassociated proteins. Am. J. Pathol. 163:1663-1675 (Pubitemid 37175113)
45. Spencer MJ, Mellgren RL. 2002. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum. Mol. Genet. 11:2645-2655 (Pubitemid 35174694)
46. Rando TA, Disatnik MH, Yu Y, Franco A. 1998. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscular Disord. 8:14-21 (Pubitemid 28174930)
47. Tidball JG. 2005. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R345-53
48. Wehling M, Spencer MJ, Tidball JG. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155:123-131 (Pubitemid 34286213)
49. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, et al. 1999. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1:215-220 (Pubitemid 129500940)
50. Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, et al. 1998. mdx muscle pathology is independent of nNOS perturbation. Hum. Mol. Genet. 7:823-829 (Pubitemid 28221245)
51. Rando TA. 2001. Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis. Microsc. Res. Tech. 55:223-235
52. Miles AM, Bohle DS, Glassbrenner PA, Hanser B, Wink DA, Grisham MB. 1996. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:40-47
53. Dudley RW, Danialou G, Govindaraju K, Lands L, Eidelman DE, Petrof BJ. 2006. Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/ nitrosative stresses. Am. J. Pathol. 168:1276-1287
54. Kar NC, Pearson CM. 1979. Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin. Chim. Acta 94:277-280
55. Touboul D, Brunelle A, Halgand F, De La Porte S, Laprevote O. 2005. Lipid imaging by gold cluster time-of-flight secondary ion mass spectrometry: application to Duchenne muscular dystrophy. J. Lipid. Res. 46:1388-1395 (Pubitemid 43109802)
56. Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, et al. 1998. Evidence of oxidative stress in mdx mouse muscle: studies of the prenecrotic state. J. Neurol. Sci. 161:77-84 (Pubitemid 28559187)
57. Ragusa RJ, Chow CK, Porter JD. 1997. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscular Disord. 7:379-386
58. Buetler TM, Renard M, Offord EA, Schneider H, Ruegg UT. 2002. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am. J. Clin. Nutr. 75:749-753 (Pubitemid 34250689)
59. Bornman L, Rossouw H, Gericke GS, Polla BS. 1998. Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem. Pharmacol. 56:751-757 (Pubitemid 28454586)
60. Backman E, Nylander E, Johansson I, Henriksson KG, Tagesson C. 1988. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function. Acta Neurol. Scand. 78:429-435
61. Fenichel GM, Brooke MH, Griggs RC, Mendell JR, Miller JP, et al. 1988. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 11:1164-1168 (Pubitemid 18263154)
62. Messina S, Altavilla D, Aguennouz M, Seminara P, Minutoli L, et al. 2006. Lipid peroxidation inhibition blunts nuclear factor-κB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168:918-926 (Pubitemid 43327744)
63. Kumar A, Boriek AM. 2003. Mechanical stress activates the nuclear factor-κB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J. 17:386-396 (Pubitemid 36292954)
64. Gosselin LE, Martinez DA. 2004. Impact of TNF-α blockade on TGF-β1 and type I collagen mRNA expression in dystrophic muscle. Muscle Nerve 30:244-246
65. Grounds MD, Torrisi J. 2004. Anti-TNFα (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 18:676-682 (Pubitemid 38451789)
66. De Luca A, Nico B, Liantonio A, Didonna MP, Fraysse B, et al. 2005. A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice. Am. J. Pathol. 166:477-489 (Pubitemid 40189044)
67. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, et al. 2006. Nuclear factor κ-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp. Neurol. 198:234-241 (Pubitemid 43243761)
68. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, et al. 2002. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11:263-272 (Pubitemid 34173355)
69. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, et al. 2003. Defective membrane repair in dysferlindeficient muscular dystrophy. Nature 423:168-172 (Pubitemid 36569539)
70. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, et al. 1999. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet. 8:855-861 (Pubitemid 29189053)
71. Achanzar WE, Ward S. 1997. A nematode gene required for sperm vesicle fusion. J. Cell Sci. 110(Pt. 9):1073-1081 (Pubitemid 27232277)
72. Davis DB, Doherty KR, Delmonte AJ, McNally EM. 2002. Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J. Biol. Chem. 277:22883-22888
73. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, et al. 1998. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat. Genet. 20:37-42 (Pubitemid 28410340)
74. Liu J, Aoki M, Illa I, Wu C, Fardeau M, et al. 1998. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat. Genet. 20:31-36 (Pubitemid 28410339)
75. Weiler T, Bashir R, Anderson LV, Davison K, Moss JA, et al. 1999. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum. Mol. Genet. 8:871-877 (Pubitemid 29189055)
76. Piccolo F, Moore SA, Ford GC, Campbell KP. 2000. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann. Neurol. 48:902-912
77. Selcen D, Stilling G, Engel AG. 2001. The earliest pathologic alterations in dysferlinopathy. Neurology 56:1472-1481
78. de Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, et al. 2006. Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro". J. Biol. Chem. 281:17092-17098
79. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr. 2003. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J. Biol. Chem. 278:50466-50473 (Pubitemid 37548892)
80. Parton RG. 1996. Caveolae and caveolins. Curr. Opin. Cell Biol. 8:542-548
81. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, et al. 1998. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18:365-368 (Pubitemid 28158166)
82. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, et al. 2001. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum. Mol. Genet. 10:1761-1766 (Pubitemid 32899093)
83. Hernandez-Deviez DJ, Martin S, Laval SH, Lo HP, Cooper ST, et al. 2006. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hum. Mol. Genet. 15:129-142 (Pubitemid 43020111)
84. Hernandez-Deviez DJ, Howes MT, Laval SH, Bushby K, Hancock JF, Parton RG. 2008. Caveolin regulates endocytosis of the muscle repair protein, dysferlin. J. Biol. Chem. 283:6476-6488
85. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, et al. 1995. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40
86. Huang Y, Verheesen P, Roussis A, Frankhuizen W, Ginjaar I, et al. 2005. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display. Eur. J. Hum. Genet. 13:721-730 (Pubitemid 40846844)
87. Anderson LV, Harrison RM, Pogue R, Vafiadaki E, Pollitt C, et al. 2000. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscular Disord. 10:553-559 (Pubitemid 30798012)
88. Huang Y, de Morree A, van Remoortere A, Bushby K, Frants RR, et al. 2008. Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle. Hum. Mol. Genet. 7:1855-1866 (Pubitemid 351791513)
89. Huang Y, Laval SH, van Remoortere A, Baudier J, Benaud C, et al. 2007. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J. 21:732-742 (Pubitemid 46348249)
90. Ando Y, Imamura S, Hong YM, Owada MK, Kakunaga T, Kannagi R. 1989. Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography. J. Biol. Chem. 264:6948-6955 (Pubitemid 19114809)
91. Cagliani R, Magri F, Toscano A, Merlini L, Fortunato F, et al. 2005. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies. Hum. Mutat. 26:283
92. McNeil AK, Rescher U, Gerke V, McNeil PL. 2006. Requirement for annexin A1 in plasma membrane repair. J. Biol. Chem. 281:35202-35207 (Pubitemid 46036558)
93. Sussman J, Stokoe D, Ossina N, Shtivelman E. 2001. Protein kinase B phosphorylates AHNAK and regulates its subcellular localization. J. Cell Biol. 154:1019-1030 (Pubitemid 34286181)
94. 2+ and synaptotagmin. J. Neurosci. Res. 62:566-573
95. Davis DB, Delmonte AJ, Ly CT, McNally EM. 2000. Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum. Mol. Genet. 9:217-226
96. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, et al. 2005. Normal myoblast fusion requires myoferlin. Development 132:5565-5575 (Pubitemid 43125882)
97. Vainzof M, Anderson LV, McNally EM, Davis DB, Faulkner G, et al. 2001. Dysferlin protein analysis in limb-girdle muscular dystrophies. J. Mol. Neurosci. 17:71-80 (Pubitemid 32928287)
98. Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, Allen RE. 1998. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 194:114-128 (Pubitemid 28115263)
99. Conboy IM, Conboy MJ, Smythe GM, Rando TA. 2003. Notch-mediated restoration of regenerative potential to aged muscle. Science 302:1575-1577
100. Conboy IM, Rando TA. 2002. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3:397-409
101. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, et al. 2005. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122:289-301 (Pubitemid 41032991)
102. Blau HM, Webster C, Pavlath GK. 1983. Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 80:4856-4860
103. Webster C, Blau HM. 1990. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat. Cell Mol. Genet. 16:557-565
104. Heslop L, Morgan JE, Partridge TA. 2000. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113(Pt. 12):2299-2308 (Pubitemid 30426843)
105. Wakayama Y, Schotland DL, Bonilla E, Orecchio E. 1979. Quantitative ultrastructural study of muscle satellite cells in Duchenne dystrophy. Neurology 29:401-407 (Pubitemid 9111029)
106. Ishimoto S, Goto I, Ohta M, Kuroiwa Y. 1983. A quantitative study of the muscle satellite cells in various neuromuscular disorders. J. Neurol. Sci. 62:303-314 (Pubitemid 14176257)
107. Matecki S, Guibinga GH, Petrof BJ. 2004. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287:R961-68 (Pubitemid 39280485)
108. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, Butler-Browne GS. 2000. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscular Disord. 10:113-120 (Pubitemid 30050623)
109. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS. 1997. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum. Gene Ther. 8:1429-1438 (Pubitemid 27393998)
110. Renault V, Piron-Hamelin G, Forestier C, DiDonna S, Decary S, et al. 2000. Skeletal muscle regeneration and the mitotic clock. Exp. Gerontol. 35:711-719 (Pubitemid 30798068)
111. Lund TC, Grange RW, Lowe DA. 2007. Telomere shortening in diaphragm and tibialis anterior muscles of aged mdx mice. Muscle Nerve 36:387-390
112. Oexle K, Zwirner A, Freudenberg K, Kohlschutter A, Speer A. 1997. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy. Pediatr. Res. 42:226-231 (Pubitemid 27311345)
113. Delaporte C, Dehaupas M, Fardeau M. 1984. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle. J. Neurol. Sci. 64:149-160 (Pubitemid 14111138)
114. Jasmin G, Tautu C, Vanasse M, Brochu P, Simoneau R. 1984. Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy. Lab. Investig. 50:197-207 (Pubitemid 14199081)
115. Melone MA, Peluso G, Petillo O, Galderisi U, Cotrufo R. 1999. Defective growth in vitro of Duchenne Muscular Dystrophy myoblasts: the molecular and biochemical basis. J. Cell Biochem. 76:118-132 (Pubitemid 30010764)
116. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, et al. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-β-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13:204-210
117. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE. 2002. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol. Biol. Cell 13:2909-2918 (Pubitemid 34907112)
118. Anderson JE. 2000. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol. Biol. Cell 11:1859-1874
119. Lee KH, Baek MY, Moon KY, Song WK, Chung CH, et al. 1994. Nitric oxide as a messenger molecule for myoblast fusion. J. Biol. Chem. 269:14371-14374 (Pubitemid 24193984)
120. Melone MA, Peluso G, Galderisi U, Petillo O, Cotrufo R. 2000. Increased expression of IGF-binding protein-5 in Duchenne muscular dystrophy (DMD) fibroblasts correlates with the fibroblast-induced downregulation of DMD myoblast growth: an in vitro analysis. J. Cell Physiol. 185:143-153
121. Philippou A, Halapas A, Maridaki M, Koutsilieris M. 2007. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J. Musculoskelet. Neuronal Interact. 7:208-218 (Pubitemid 350238147)
122. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. 2002. Muscle-specific expression of insulinlike growth factor I counters muscle decline in mdx mice. J. Cell Biol. 157:137-148 (Pubitemid 34847836)
123. Merly F, Lescaudron L, Rouaud T, Crossin F, Gardahaut MF. 1999. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22:724-732 (Pubitemid 29256841)
124. Grounds MD. 1998. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann. N. Y. Acad. Sci. 854:78-91 (Pubitemid 29022795)
125. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433:760-764
126. Wallace GQ, Lapidos KA, Kenik JS, McNally EM. 2008. Long-term stem survival of transplanted cells in immunocompetent mice with muscular dystrophy. Am. J. Pathol. 173:792-802
127. Bione S, Maestrini E, Rivella S, Mancini M, Regis S, et al. 1994. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat. Genet. 8:323-327 (Pubitemid 24375595)
128. Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, et al. 1999. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21:285-288 (Pubitemid 29124935)
129. Muchir A, Bonne G, Van Der Kooi AJ, van Meegen M, Baas F, et al. 2000. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9:1453-1459 (Pubitemid 30312494)
130. Todorova A, Halliger-Keller B, Walter MC, Dabauvalle MC, Lochmuller H, Muller CR. 2003. Asynonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B. J. Med. Genet. 40:e115
131. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, et al. 1999. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341:1715-1724
132. Manilal S, Nguyen TM, Sewry CA, Morris GE. 1996. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum. Mol. Genet. 5:801-808 (Pubitemid 26171704)
133. Goldman RD, Goldman AE, Shumaker DK. 2005. Nuclear lamins: building blocks of nuclear structure and function. Novartis Found. Symp. 264:3-16
134. Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, et al. 2006. Coupling of the nucleus and cytoplasm: role of the LINC complex. J. Cell Biol. 172:41-53 (Pubitemid 43042628)
135. Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, et al. 2003. Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription. Exp. Cell Res. 291:122-134 (Pubitemid 37345152)
136. Favreau C, Dubosclard E, Ostlund C, Vigouroux C, Capeau J, et al. 2003. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp. Cell Res. 282:14-23 (Pubitemid 36062608)
137. Muchir A, Medioni J, Laluc M, Massart C, Arimura T, et al. 2004. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve 30:444-450 (Pubitemid 39288147)
138. Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau J, et al. 2001. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J. Cell Sci. 114:4459-4468 (Pubitemid 34082866)
139. Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL, Lee RT. 2005. Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J. Cell Biol. 170:781-791 (Pubitemid 41242110)
140. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, et al. 2004. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Investig. 113:370-378 (Pubitemid 38544181)
141. -/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum. Mol. Genet. 13:2567-2580
142. Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, et al. 2004. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J. Clin. Investig. 113:357-369 (Pubitemid 38544180)
143. Melcon G, Kozlov S, Cutler DA, Sullivan T, Hernandez L, et al. 2006. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum. Mol. Genet. 15:637-651 (Pubitemid 43205427)
144. Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, et al. 2006. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 129:996-1013
145. Frock RL, Kudlow BA, Evans AM, Jameson SA, Hauschka SD, Kennedy BK. 2006. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev. 20:486-500
146. Favreau C, Higuet D, Courvalin JC, Buendia B. 2004. Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol. Cell. Biol. 24:1481-1492 (Pubitemid 38167072)
147. Markiewicz E, Ledran M, Hutchison CJ. 2005. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J. Cell Sci. 118:409-420 (Pubitemid 40277352)
148. Parnaik VK, Manju K. 2006. Laminopathies: multiple disorders arising from defects in nuclear architecture. J. Biosci. 31:405-421 (Pubitemid 44411514)
149. -/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144:631-643
150. Yablonka-Reuveni Z, Rudnicki MA, Rivera AJ, Primig M, Anderson JE, Natanson P. 1999. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev. Biol. 210:440-455 (Pubitemid 29283015)
151. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10:1173-1183 (Pubitemid 26171100)
152. -/- satellite cells in single-fiber culture are differentiation defective and MRF4 deficient. Dev. Biol. 224:122-137